Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.54ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-2207.87South Korea
BA.5.2.54ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
BA.5.2.54SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.54SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-18758.6South Korea
BA.5.2.54EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.54NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.54NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DR.2ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
DR.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
DR.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
DR.2SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
DR.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DR.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DR.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.27ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BF.7.27ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BF.7.27SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BF.7.27SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BF.7.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.26ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.26ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.26SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.1.26SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BQ.1.1.72SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
BQ.1.1.72SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BQ.1.1.72EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.72EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.72NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.72NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBJ.2ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
XBJ.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XBJ.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBJ.2SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XBJ.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XBJ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBJ.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.14ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BF.14ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BF.14SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BF.14SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BF.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used